Homocystéine et risque cardiovasculaire: de l'utilité du dosage [Homocystein and cardiovascular risk: is dosage useful?]

Details

Serval ID
serval:BIB_D7A7DA52B686
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Homocystéine et risque cardiovasculaire: de l'utilité du dosage [Homocystein and cardiovascular risk: is dosage useful?]
Journal
Praxis
Author(s)
Mathez C.h., Trueb L., Darioli R., Waeber G.
ISSN
1661-8157
Publication state
Published
Issued date
2004
Volume
93
Number
50
Pages
2093-7
Language
french
Notes
Publication types: English Abstract ; Journal Article - Publication Status: ppublish
Abstract
Hyperhomocysteinemia represents an independent risk factor for atherothrombotic disease. Physiopathological mechanisms of accelerated progression of atherosclerosis in presence of hyperhomocysteinemia are complex. Herein we report a clinical case which emphasis the importance of screening elevated homocystein in the absence of conventional risk factors in patients who suffer from premature atherosclerosis.
Keywords
Adult, Coronary Artery Disease, DNA Mutational Analysis, Heterozygote Detection, Homocysteine, Humans, Male, Methylenetetrahydrofolate Reductase (NADPH2), Myocardial Infarction, Protein S Deficiency, Prothrombin, Recurrence, Risk Factors, Thrombophilia
Pubmed
Create date
28/01/2008 11:45
Last modification date
20/08/2019 15:57
Usage data